- Home
- GDEV vs SOPH Comparison
GDEV vs SOPH Comparison
Compare GDEV & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDEV | SOPH |
|---|---|---|
| Founded | 2009 | 2011 |
| Country | Cyprus | Switzerland |
| Employees | 589 | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 308.9M | 330.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GDEV | SOPH |
|---|---|---|
| Price | $17.04 | $4.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 6.9K | ★ 99.0K |
| Earning Date | 11-24-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.98 | N/A |
| EPS | ★ 3.08 | N/A |
| Revenue | ★ $412,018,000.00 | $73,297,000.00 |
| Revenue This Year | N/A | $18.32 |
| Revenue Next Year | $4.89 | $15.61 |
| P/E Ratio | $5.53 | ★ N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $8.60 | $2.58 |
| 52 Week High | $42.20 | $5.30 |
Technical Indicators
Market Signals| Indicator | GDEV | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 49.85 |
| Support Level | $15.77 | $4.63 |
| Resistance Level | $17.88 | $4.95 |
| Average True Range (ATR) | 1.31 | 0.27 |
| MACD | 0.08 | -0.03 |
| Stochastic Oscillator | 14.22 | 17.11 |
Price Performance
Historical ComparisonAbout GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.